Highly efficient influenza matrix (M1) proteins

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9464276
SERIAL NO

14628513

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention discloses a method of increasing production of virus-like particles comprising expressing an avian influenza matrix protein. The invention also comprises methods of making and using said VLPs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
NOVAVAX INC700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kort, Thomas Germantown, US 9 49
Massare, Michael Mt. Airy, US 8 144
Nathan, Margaret Montgomery Village, US 3 18
Pushko, Peter Frederick, US 55 897
Robinson, Robin Gaithersburg, US 4 49
Smith, Gale Gaithersburg, US 70 738
Wu, Yingyun Clarksburg, US 17 298

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 11, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00